GOGO Q1 2026 Earnings EPS Beat Highlights Cost Discipline Stock Edges Lower OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Portfolio Performance Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline RCL Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Slips SLN Q4 2024 Earnings Positive EPS Amid Continued Clinical Progress CBNK Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operating Environment